- Home
- CODX vs GRFX Comparison
CODX vs GRFX Comparison
Compare CODX & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- GRFX
- Stock Information
- Founded
- CODX 2013
- GRFX 1981
- Country
- CODX United States
- GRFX Hong Kong
- Employees
- CODX N/A
- GRFX N/A
- Industry
- CODX Medical/Dental Instruments
- GRFX
- Sector
- CODX Health Care
- GRFX
- Exchange
- CODX Nasdaq
- GRFX Nasdaq
- Market Cap
- CODX 22.0M
- GRFX 18.1M
- IPO Year
- CODX 2017
- GRFX N/A
- Fundamental
- Price
- CODX $0.71
- GRFX $0.26
- Analyst Decision
- CODX Hold
- GRFX Hold
- Analyst Count
- CODX 1
- GRFX 1
- Target Price
- CODX $1.50
- GRFX N/A
- AVG Volume (30 Days)
- CODX 139.9K
- GRFX 73.4K
- Earning Date
- CODX 03-13-2025
- GRFX 01-01-0001
- Dividend Yield
- CODX N/A
- GRFX N/A
- EPS Growth
- CODX N/A
- GRFX N/A
- EPS
- CODX N/A
- GRFX N/A
- Revenue
- CODX $7,321,012.00
- GRFX $30,019,108.00
- Revenue This Year
- CODX N/A
- GRFX N/A
- Revenue Next Year
- CODX N/A
- GRFX N/A
- P/E Ratio
- CODX N/A
- GRFX N/A
- Revenue Growth
- CODX 57.16
- GRFX N/A
- 52 Week Low
- CODX $0.65
- GRFX $0.14
- 52 Week High
- CODX $2.23
- GRFX $0.55
- Technical
- Relative Strength Index (RSI)
- CODX 43.93
- GRFX 50.90
- Support Level
- CODX $0.69
- GRFX $0.23
- Resistance Level
- CODX $0.73
- GRFX $0.27
- Average True Range (ATR)
- CODX 0.04
- GRFX 0.02
- MACD
- CODX 0.00
- GRFX 0.00
- Stochastic Oscillator
- CODX 42.31
- GRFX 79.18
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.